Axa S.A. Exact Sciences Corp Transaction History
Axa S.A.
- $29.5 Billion
- Q1 2025
A detailed history of Axa S.A. transactions in Exact Sciences Corp stock. As of the latest transaction made, Axa S.A. holds 556,650 shares of EXAS stock, worth $30.3 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
556,650
Previous 596,221
6.64%
Holding current value
$30.3 Million
Previous $33.5 Million
28.07%
% of portfolio
0.08%
Previous 0.1%
Shares
36 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$970 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$959 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$680 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$656 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$360 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.62B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...